Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St. Jude Symmetry

This article was originally published in The Gray Sheet

Executive Summary

Sutureless aortic connector anastomosis system gains 510(k) clearance for use to attach vein grafts to the aorta during coronary artery bypass grafting surgery (1"The Gray Sheet" May 7, 2001, p. 14). The second planned product in the Symmetry line, a coronary connector to connect the other end of the vein to the coronary arteries, is in clinical studies. Use of the Symmetry system is anticipated to simplify bypass and help increase the appeal of less invasive CABG compared to alternatives such as open-chest CABG or stenting

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014936

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel